| 2025 |
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT model |
Articolo in rivista |
Vai |
| 2025 |
Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis |
Articolo in rivista |
Vai |
| 2025 |
ITA-MASLD: A national observational study to characterize the profile of patients with MASLD in specialistic care in Italy |
Articolo in rivista |
Vai |
| 2025 |
Prevalence and heterogeneity of antinuclear antibody patterns in adult Italian patients with autoimmune liver diseases: Our experience |
Articolo in rivista |
Vai |
| 2025 |
Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study |
Articolo in rivista |
Vai |
| 2025 |
Management of Hepatitis B virus infection in patients on treatment with immunosuppressants or immunomodulators: Position Paper of Associazione Italiana Studio del Fegato (AISF), Associazione Italiana di Oncologia Medica (AIOM), Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Società Italiana di Reumatologia (SIR), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Gastroenterologia (SIGE), Società Italiana di Malattie Infettive e Tropicali (SIMIT) |
Articolo in rivista |
Vai |
| 2025 |
Impact of first and further decompensation in patients with compensated ACLD due to MASLD |
Articolo in rivista |
Vai |
| 2024 |
Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV- and HCV-Related Cirrhosis: A Comprehensive Review |
Articolo in rivista |
Vai |
| 2024 |
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis |
Articolo in rivista |
Vai |
| 2024 |
What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis |
Review essay (rassegna critica) |
Vai |
| 2024 |
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? |
Articolo in rivista |
Vai |
| 2024 |
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study |
Articolo in rivista |
Vai |
| 2024 |
Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physicians |
Articolo in rivista |
Vai |
| 2024 |
Real-Time Gastric Juice Analysis in Cirrhotic Patients: Can We Avoid Unrewarding Gastric Biopsies? |
Articolo in rivista |
Vai |
| 2024 |
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis |
Articolo in rivista |
Vai |
| 2024 |
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study |
Articolo in rivista |
Vai |
| 2024 |
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) |
Articolo in rivista |
Vai |
| 2024 |
Real-world experience with long-term albumin in patients with cirrhosis and ascites |
Articolo in rivista |
Vai |
| 2024 |
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms |
Articolo in rivista |
Vai |
| 2024 |
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis |
Articolo in rivista |
Vai |
| 2024 |
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis |
Articolo in rivista |
Vai |
| 2024 |
Quantitative Evaluation by Digital Pathology of Immunohistochemical Expression of CK7, CK19, and EpCAM in Advanced Stages of NASH |
Articolo in rivista |
Vai |
| 2023 |
Depth effect on point shear wave velocity elastography: Evidence in a chronic hepatitis C patient cohort |
Articolo in rivista |
Vai |
| 2023 |
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study |
Articolo in rivista |
Vai |
| 2023 |
Heart rate variability is associated with disease severity and portal hypertension in cirrhosis |
Articolo in rivista |
Vai |
| 2023 |
Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity |
Articolo in rivista |
Vai |
| 2023 |
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study |
Articolo in rivista |
Vai |
| 2023 |
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
| 2023 |
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort |
Articolo in rivista |
Vai |
| 2023 |
Child-Pugh Class and Not Thrombocytopenia Impacts the Risk of Complications of Endoscopic Band Ligation in Patients with Cirrhosis and High Risk Varices |
Articolo in rivista |
Vai |
| 2023 |
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight |
Articolo in rivista |
Vai |
| 2023 |
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort |
Articolo in rivista |
Vai |
| 2022 |
Corrigendum to 'Baveno VII - Renewing consensus in portal hypertension' [J Hepatol (2022) 959-974] |
Nota o commento |
Vai |
| 2022 |
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices |
Articolo in rivista |
Vai |
| 2022 |
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid |
Articolo in rivista |
Vai |
| 2022 |
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis |
Articolo in rivista |
Vai |
| 2022 |
Baveno VII – Renewing consensus in portal hypertension |
Articolo in rivista |
Vai |
| 2022 |
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development |
Articolo in rivista |
Vai |
| 2022 |
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) |
Nota o commento |
Vai |
| 2022 |
Primary biliary cholangitis: perception and expectation of illness |
Articolo in rivista |
Vai |
| 2022 |
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model |
Articolo in rivista |
Vai |
| 2021 |
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort |
Articolo in rivista |
Vai |
| 2021 |
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy |
Articolo in rivista |
Vai |
| 2021 |
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort |
Articolo in rivista |
Vai |
| 2021 |
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials |
Articolo in rivista |
Vai |
| 2021 |
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study |
Articolo in rivista |
Vai |
| 2021 |
Reply to: “Hepatic benefits of HCV cure: Don't forget coagulation!” |
Recensione in rivista |
Vai |
| 2021 |
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals |
Articolo in rivista |
Vai |
| 2021 |
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach |
Articolo in rivista |
Vai |
| 2021 |
Real-world experience with obeticholic acid in patients with primary biliary cholangitis. |
Articolo in rivista |
Vai |
| 2021 |
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis. |
Articolo in rivista |
Vai |
| 2021 |
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C |
Articolo in rivista |
Vai |
| 2021 |
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease |
Articolo in rivista |
Vai |
| 2021 |
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs. |
Articolo in rivista |
Vai |
| 2021 |
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b. |
Articolo in rivista |
Vai |
| 2020 |
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study |
Articolo in rivista |
Vai |
| 2020 |
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study |
Articolo in rivista |
Vai |
| 2020 |
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) |
Articolo in rivista |
Vai |
| 2020 |
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites |
Articolo in rivista |
Vai |
| 2020 |
Hepatic benefits of HCV cure |
Articolo in rivista |
Vai |
| 2020 |
Towards personalized screening for hepatocellular carcinoma: Still not there |
Recensione in rivista |
Vai |
| 2020 |
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis |
Articolo in rivista |
Vai |
| 2019 |
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data |
Articolo in rivista |
Vai |
| 2019 |
Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program. |
Articolo in rivista |
Vai |
| 2019 |
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. |
Articolo in rivista |
Vai |
| 2019 |
Current epidemiology of HCV in Sicily: the RESIST-HCV model |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2019 |
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience |
Articolo in rivista |
Vai |
| 2019 |
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy |
Articolo in rivista |
Vai |
| 2019 |
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) |
Articolo in rivista |
Vai |
| 2019 |
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Articolo in rivista |
Vai |
| 2019 |
Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients |
Articolo in rivista |
Vai |
| 2018 |
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals |
Articolo in rivista |
Vai |
| 2018 |
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? |
Lettera |
Vai |
| 2018 |
Is global elimination of HCV realistic? |
Articolo in rivista |
Vai |
| 2018 |
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents |
Articolo in rivista |
Vai |
| 2018 |
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study |
Articolo in rivista |
Vai |
| 2018 |
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents |
Articolo in rivista |
Vai |
| 2018 |
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort |
Poster pubblicato in rivista |
Vai |
| 2018 |
Predictors of Re‐bleeding and Mortality Among Patients
with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS) |
Articolo in rivista |
Vai |
| 2018 |
The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2018 |
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis |
Articolo in rivista |
Vai |
| 2018 |
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals. |
Articolo in rivista |
Vai |
| 2018 |
Real life experiences in HCV management in 2018 |
Articolo in rivista |
Vai |
| 2018 |
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma. |
Articolo in rivista |
Vai |
| 2018 |
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis |
Articolo in rivista |
Vai |
| 2018 |
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. |
Articolo in rivista |
Vai |
| 2018 |
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) |
Nota o commento |
Vai |
| 2018 |
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis |
Articolo in rivista |
Vai |
| 2017 |
HBV recurrence after HCV clearance on DAAs: Sometimes they come back |
Nota o commento |
Vai |
| 2017 |
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response |
Articolo in rivista |
Vai |
| 2017 |
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens |
Articolo in rivista |
Vai |
| 2017 |
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV |
Articolo in rivista |
Vai |
| 2017 |
Hepatocellular carcinoma and direct-acting antivirals: A never ending story? |
Articolo in rivista |
Vai |
| 2017 |
A focus on epidemiology of drug-induced liver injury: analysis of a prospective cohort |
Articolo in rivista |
Vai |
| 2017 |
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication |
Articolo in rivista |
Vai |
| 2017 |
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network |
Articolo in rivista |
Vai |
| 2017 |
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study |
Articolo in rivista |
Vai |
| 2017 |
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study |
Articolo in rivista |
Vai |
| 2017 |
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies |
Articolo in rivista |
Vai |
| 2017 |
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study |
Articolo in rivista |
Vai |
| 2017 |
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel |
Articolo in rivista |
Vai |
| 2016 |
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model |
Articolo in rivista |
Vai |
| 2016 |
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension |
Articolo in rivista |
Vai |
| 2016 |
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference |
Articolo in rivista |
Vai |
| 2016 |
AISF position paper on liver disease and pregnancy. |
Articolo in rivista |
Vai |
| 2016 |
Why do I treat my patients with mild hepatitis C? |
Articolo in rivista |
Vai |
| 2016 |
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels |
Articolo in rivista |
Vai |
| 2016 |
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication? |
Articolo in rivista |
Vai |
| 2016 |
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. |
Articolo in rivista |
Vai |
| 2016 |
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF). |
Articolo in rivista |
Vai |
| 2016 |
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease |
Articolo in rivista |
Vai |
| 2015 |
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis |
Articolo in rivista |
Vai |
| 2015 |
Meccanismi immunologici e molecolari del danno epatico da farmaci |
Articolo in rivista |
Vai |
| 2015 |
Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye. |
Review essay (rassegna critica) |
Vai |
| 2015 |
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis |
Articolo in rivista |
Vai |
| 2015 |
Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis. |
Articolo in rivista |
Vai |
| 2015 |
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program |
Articolo in rivista |
Vai |
| 2015 |
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis |
Articolo in rivista |
Vai |
| 2014 |
Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis. |
Articolo in rivista |
Vai |
| 2014 |
Clinical implications of the hyperdynamic syndrome in cirrhosis. |
Articolo in rivista |
Vai |
| 2014 |
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
| 2014 |
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin |
Articolo in rivista |
Vai |
| 2014 |
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene |
Abstract in rivista |
Vai |
| 2014 |
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? |
Articolo in rivista |
Vai |
| 2013 |
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC |
Abstract in rivista |
Vai |
| 2013 |
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B |
Articolo in rivista |
Vai |
| 2013 |
Digital image analysis of collagen assessment of progression of fibrosis in
recurrent HCV after liver transplantation |
Articolo in rivista |
Vai |
| 2013 |
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. |
Articolo in rivista |
Vai |
| 2013 |
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis |
Abstract in rivista |
Vai |
| 2013 |
Immunological alterations in hepatitis C virus infection |
Articolo in rivista |
Vai |
| 2013 |
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis. |
Articolo in rivista |
Vai |
| 2013 |
MECCANISMI IMMUNOLOGICI E MOLECOLARI DEL DANNO EPATICO DA FARMACI |
Proceedings |
Vai |
| 2013 |
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance |
Articolo in rivista |
Vai |
| 2013 |
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal
varices in patients with compensated hepatitis C virus cirrhosis |
Articolo in rivista |
Vai |
| 2013 |
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. |
Articolo in rivista |
Vai |
| 2012 |
Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation |
Articolo in rivista |
Vai |
| 2012 |
The
relationship between transient elastography and histological collagen
proportionate area for assessing fibrosis in chronic viral hepatitis |
Articolo in rivista |
Vai |
| 2012 |
Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea |
Articolo in rivista |
Vai |
| 2012 |
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV |
Abstract in rivista |
Vai |
| 2012 |
IL28B polymorphisms influence stage of fibrosis and
spontaneous or interferon-induced viral clearance in thalassemia patients with
hepatitis C virus infection. |
Articolo in rivista |
Vai |
| 2011 |
LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION |
Abstract in rivista |
Vai |
| 2011 |
Pegylated-interferon-α(2a) in clinical
practice: how to manage patients suffering from side effects |
Articolo in rivista |
Vai |
| 2011 |
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
| 2011 |
Comparison of cystatin C and creatinine-based glomerular filtration
rate formulas with 51Cr-EDTA clearance in patients with cirrhosis |
Articolo in rivista |
Vai |
| 2011 |
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis |
Recensione in rivista |
Vai |
| 2011 |
COMPUTER ASSISTED IMAGE ANALYSIS OF LIVER COLLAGEN: RELATIONSHIP TO ESOPHAGEAL VARICES, LIVER DECOMPENSATION AND SVR IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS |
Tesi di dottorato pre 2013 |
Vai |
| 2011 |
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients |
Articolo in rivista |
Vai |
| 2011 |
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE |
Abstract in rivista |
Vai |
| 2011 |
Digital image analysis of liver collagen predicts clinical
outcome of recurrent hepatitis C virus 1 year after liver transplantation. |
Articolo in rivista |
Vai |
| 2011 |
Fibrosis in chronic viral hepatitis |
Articolo in rivista |
Vai |
| 2010 |
Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. |
Articolo in rivista |
Vai |
| 2010 |
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy |
Articolo in rivista |
Vai |
| 2010 |
Histological subclassification of cirrhosis |
Recensione in rivista |
Vai |
| 2010 |
Critically ill patients with cirrhosis and low serum sodium. |
Articolo in rivista |
Vai |
| 2010 |
Hepassocin as a treatment for fulminant hepatic failure: will it
translate from rats to human? |
Recensione in rivista |
Vai |
| 2009 |
Impact of Tips Preliver Transplantation
for the Outcome Posttransplantation |
Articolo in rivista |
Vai |
| 2009 |
RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. |
Articolo in rivista |
Vai |
| 2009 |
Computer-Assisted Image Analysis of Liver Collagen:
Relationship to Ishak Scoring and Hepatic Venous
Pressure Gradient |
Articolo in rivista |
Vai |
| 2009 |
Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. |
Articolo in rivista |
Vai |
| 2009 |
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers |
Articolo in rivista |
Vai |
| 2009 |
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis |
Articolo in rivista |
Vai |
| 2009 |
Implication of Normal Liver Enzymes in Liver Disease |
Articolo in rivista |
Vai |
| 2009 |
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings |
Vai |
| 2009 |
A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation. |
Articolo in rivista |
Vai |
| 2009 |
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. |
Articolo in rivista |
Vai |
| 2009 |
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy |
Articolo in rivista |
Vai |
| 2009 |
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings |
Vai |
| 2009 |
HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION |
Abstract in rivista |
Vai |
| 2009 |
PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE |
Abstract in rivista |
Vai |
| 2008 |
CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY |
Proceedings |
Vai |
| 2008 |
Models for non-alcoholic fatty liver disease: a link with vascular risk. |
Articolo in rivista |
Vai |
| 2008 |
Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. |
Articolo in rivista |
Vai |
| 2008 |
TACE versus TAE as therapy for hepatocellular carcinoma. |
Articolo in rivista |
Vai |
| 2008 |
Coagulation and fibrosis in chronic liver disease. |
Articolo in rivista |
Vai |
| 2008 |
Muscle cramps in cirrhosis: the therapeutic value of quinine. Is it underused? |
Articolo in rivista |
Vai |
| 2007 |
The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study |
Proceedings |
Vai |
| 2007 |
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study |
Proceedings |
Vai |
| 2007 |
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial |
Articolo in rivista |
Vai |
| 2006 |
High rate of spontaneous viral clearance in patients with iatrogenic acute hepatitis C |
Articolo in rivista |
Vai |
| 2006 |
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial |
Articolo in rivista |
Vai |
| 2006 |
The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. |
Articolo in rivista |
Vai |
